Cyclobutane derivatives as potent NK1 selective antagonists

Abstract A series of novel cyclobutane derivatives as potent and selective NK 1 receptor antagonists is described. Several compounds in this series exhibited high in vitro binding affinity ( K i  ⩽ 1 nM), and potent inhibition of central NK 1 receptor following oral administration. Syntheses of these compounds are also described herein.